Equities

Themis Medicare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
THEMISMED:NSI

Themis Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)90.28
  • Today's Change-0.270 / -0.30%
  • Shares traded36.92k
  • 1 Year change-43.82%
  • Beta1.2765
Data delayed at least 15 minutes, as of Feb 18 2026 09:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.

  • Revenue in INR (TTM)3.37bn
  • Net income in INR-174.06m
  • Incorporated1969
  • Employees1.76k
  • Location
    Themis Medicare Ltd11/12 Udyog Nagar, S V Road, Goregaon (West)MUMBAI 400104IndiaIND
  • Phone+91 2 267607080
  • Fax+91 2 228746621
  • Websitehttps://www.themismedicare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shri Ahimsa Naturals Ltd1.16bn266.73m5.78bn--16.833.4120.265.0014.6514.6561.2372.370.79571.804.75--18.3625.5519.4231.5148.6353.5023.0725.1912.68--0.00--22.8634.7517.3178.7053.34--
Kopran Ltd6.20bn165.43m6.40bn1.02k38.85--19.181.033.413.41128.28--------6,052,426.00--7.85--11.2534.2032.042.678.66--2.39--29.602.4411.86-24.3412.9033.20--
Anlon Healthcare Ltd1.70bn346.64m6.46bn101.0016.49--17.603.807.377.3737.66------------------38.31--20.39----11.05----80.65--112.46------
Fabtech Technologies Ltd3.87bn313.94m7.12bn--16.19--19.751.849.899.89115.93------------------44.01--8.11----------44.46--70.67------
Accent Microcell Ltd2.78bn346.64m7.84bn192.0021.463.1420.162.8215.2415.24122.20104.071.124.145.3214,474,330.0013.99--15.95--39.96--12.47--3.0176.480.0046--7.77--9.60------
Remus Pharmaceuticals Ltd7.48bn325.59m8.07bn68.0022.022.6318.351.0831.1131.11701.20260.511.899.077.21109,981,700.0010.4414.3718.4428.6013.0119.395.518.391.0735.590.04523.59191.93120.4434.98104.5648.07--
Anuh Pharma Ltd7.68bn418.22m8.19bn295.0019.57--15.471.074.174.1776.65--------26,023,040.00--10.41--17.0022.2523.955.457.35--116.27--26.592.2416.60-21.1627.05-10.7816.89
Themis Medicare Ltd3.37bn-174.06m8.38bn1.76k------2.49-1.89-1.8936.52--------1,917,083.00--10.17--14.3862.5660.61-5.1613.52---3.71--9.366.2215.00-31.463.7821.5823.36
Sigachi Industries Ltd5.06bn-550.46m8.82bn1.10k--1.74--1.74-1.46-1.4613.2013.290.63162.402.804,624,222.00-6.7012.29-9.7716.2152.8351.93-10.6214.801.275.530.24364.2322.3828.5521.6627.9148.87--
Wanbury Ltd6.58bn646.86m9.00bn1.38k13.47--11.371.3719.1319.13194.16--------4,758,967.00--8.87--101.4055.0741.829.845.62--2.97----4.1510.29-45.44-13.8844.32--
Venus Remedies Ltd7.00bn762.95m10.01bn1.30k13.12--10.021.4357.1057.10523.77--------5,391,957.00--6.67--8.0847.0237.6210.906.87--1,849.19----7.7213.8159.05--18.36--
Sakar Healthcare Ltd2.31bn252.21m10.77bn342.0042.25--22.284.6611.4511.45104.95--------6,750,901.00--4.73--5.6452.5445.5510.929.87--3.66----15.8016.4449.9612.7119.34--
Data as of Feb 18 2026. Currency figures normalised to Themis Medicare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

0.06%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 30 Nov 202542.96k0.05%
Dimensional Fund Advisors Ltd.as of 30 Nov 20257.28k0.01%
Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025859.000.00%
Bandhan AMC Ltd.as of 31 Jan 2026363.000.00%
DFA Australia Ltd.as of 30 Nov 2025182.000.00%
More ▼
Data from 31 Dec 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.